New pill shows promise for stubborn cough that Won't quit
NCT ID NCT05733533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough—a persistent cough that doesn't respond to usual treatments. Participants took the drug or a placebo for 4 weeks to see if it reduced cough severity and improved quality of life. The goal is to find a safe, effective option for people who have suffered from chronic cough for over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC COUGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill aims to silence chronic cough that Won't quit
- New pill aims to silence stubborn chronic cough
- New hope for chronic coughers: experimental drug enters final testing phase
- Can cough training and a natural inhaler silence chronic cough?
- New database aims to unravel mysteries of chronic cough
- New cough pill shows promise in clinical trial